Deep Dive: Deckers Outdoor Corp ($DECK)
Deckers trades at about 11x earnings as investors question whether UGG and HOKA can sustain growth after generating 97% of FY26 revenue.
Deckers trades at about 11x earnings as investors question whether UGG and HOKA can sustain growth after generating 97% of FY26 revenue.
@thecontracap @jclarkson203 Just a reminder that those $PSA yield 240 bps wide of the 10 yr. During GFC, EBITDA of PSA dropped less than 10%. They need to drop more than 80% for distribution to be in trouble. I’ll just deal with the vol. if no taxes in IRA etc. Then it’s a no brainer by my reasoning.
@jclarkson203 Again, it’s about knowing what I own. IDGAF if $PSA pref goes down. I’ll buy more.
I’ll take the other side of that During the GFC, EBITDA declined less than 10% for $PSA JPM was fine, but other big bank almost went under This is a “negative art” where you want to eliminate that tail risk Dimon there, fine. Dimon not there. Not sure. Lehman and Wachovia wasn’t so lucky.
Because when shit hits the fan, I know that $PSA interest/pref is covered 6.1 times I don’t know how to read a bank balance sheet I know that you probably can’t make a $78 bn of self storage EBITDA go down more than 80% I know what I know. JPM is probably fine as long as Dimon is there.
@MBrooks87621 $tenb
@BryanFaulkCPA The current policy limiting new purchases is by default forcing Invitation to become a buyback machine IMO, it’s a gift from the politicians the same way that $NVR’s debt holders force them to use options on land after the bankruptcy
Grand Theft Auto VI launched to a 99 Metacritic score after estimated $1.5 billion to $2 billion development and marketing spending,…
Natera grew Q3 revenue 34% to $794 million, raised 2026 guidance to $3.005 billion to $3.035 billion, and named oncology head Solomon…
NatWest trades below 8x 2026 consensus EPS after weaker net interest margin guidance, despite multi-year-high profitability, solid credit…
Intuit’s $3.68 billion Mailchimp sale removes a noncore unit as TurboTax shifts to assisted filing and Credit Karma faces volume pressure.
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual…
NIQ Global Intelligence grew Q3 Intelligence subscription revenue 5.5% and adjusted EBITDA 17.8%, cutting net leverage to 2.9x while…
Intuit shares fell 9.8% after chatbots slowed Credit Karma, while QuickBooks grew mid-teens and FY27 guidance stayed unchanged.
Bloom Energy's revenue rose 138% year over year as data center moratoriums pressured its shares.
Ford trades 35% below its May 2026 high as investors treat Model e's roughly $4 billion annual loss as permanent despite higher EBIT…
Nu Holdings is expanding banking in Brazil, Mexico, Colombia and the US while investors scrutinize Brazilian credit quality and lending…
BSX · long Boston Scientific, the interventional cardiac-device leader, is rated long after a share-price and P/E decline tied to slower market growth…
StandardAero’s exclusive engine licenses and LEAP aftermarket position underpin a projected rise in LEAP revenue from $100 million in 2025…
TSOH Weekly Roundup tracks Dick’s Sporting Goods’ Foot Locker setback and Brown-Forman’s internal debate over a potential Pernod Ricard…
Sandisk’s FY28-FY30 model relies on long-term NAND agreements holding near-80% gross-margin floors despite pricing 26-28% below current…
Comcast's mobile growth, Verizon roaming agreement, NBCUniversal content and theme parks are positioned to offset broadband competition…
QXO is building a North American construction-products distributor through Beacon, Kodiak and TopBuild, targeting $18.1 billion of combined…
AEVEX faces an eFY27 contract rollover after buying maritime drone maker BlackSea for $650 million, testing whether its 55-nation pipeline…
Amprius Technologies, after a 50% decline, reported 125.7% revenue growth and raised 2026 guidance to at least $140 million as…
Higher rates could compress equity multiples and raise AI data center lease costs, while UWMC and Cogent raise questions about CEO-driven…
Biohaven’s $795 million global opakalim licensing deal with SK Biopharmaceuticals boosts cash, lowers R&D spending and extends its funding…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.